Company Filing History:
Years Active: 2019-2023
Title: **The Innovative Mind of Benjamin Lance Catt**
Introduction
Benjamin Lance Catt, an inventive force based in Auckland, New Zealand, has made significant contributions to the fields of medication delivery and monitoring. With a portfolio of seven patents, his work showcases a commitment to enhancing healthcare technology and patient adherence to treatment regimens.
Latest Patents
Among his latest innovations is the "Adherence Monitor for a Medicament Inhaler with Tethered Cap." This ingenious device integrates seamlessly with inhaler devices, featuring a tether opening that allows for a streamlined design without increasing the path length of the tether. The monitor is equipped with various sensors to detect inhaler usage, significantly improving the tracking of patient adherence. Another notable patent is the "Compliance Monitor for a Medicament Infuser," which further illustrates Catt's dedication to improving medication adherence for patients.
Career Highlights
Throughout his career, Benjamin Catt has collaborated with notable companies in the healthcare sector. He has contributed to Adherium Limited and Lograr Group Limited, where his innovations have aimed at enhancing patient care and medication compliance. These companies reflect a commitment to integrating technology into healthcare solutions for better patient outcomes.
Collaborations
Catt has worked alongside talented individuals such as Garth Campbell Sutherland and Michael James Gormack. These collaborations have undoubtedly played a role in his innovative process, facilitating the development of practical solutions that address real-world healthcare challenges.
Conclusion
Benjamin Lance Catt stands out as an inventor whose work is rooted in the enhancement of medical technologies. With seven patents to his name, his innovations are poised to make a meaningful impact in the field of medication adherence and patient care. As the landscape of healthcare technology evolves, Catt's contributions will continue to be pivotal in shaping the future of medication delivery and adherence monitoring.